References
- Ding Y, Wang Y, Zhou JP, Gu XC, Wang W, Liu CY, Bao XL, Wang C, Li YR, Zhang Q. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis. Biomaterials, 2014;35(25):7214–77.
- Fenske SA, Yesilaltay A, Pal R, Daniels K, Barker C, Quinones V, Rigotti A, Krieger M, Kocher O. Normal hepatic cell surface localization of the high density lipoprotein receptor, scavenger receptor class B, type I, depends on all four PDZ domains of PDZK1. J Biol Chem, 2009;284(9):5797–806.
- Fu YP, Wang R, Li TW, Jia L, Lin XL, Chen Y. Pharmacokinetics and tissues distribution of TJXG nano emulsion in rats. Chin Med Her, 2013;11(10):19–21.
- Lacko AG, Nair M, Paranjape S, Johnson S, McConathy WJ. High density lipoprotein complexes as delivery vehicles for anticancer drugs. Anticancer Res, 2002;22(4):2045–9.
- Ma Y, Zhuang Y, Xie X, Wang C, Wang F, Zhou D, Zeng J, Cai L. The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses. Nanoscale, 2011;3(5):2307–14.
- Mo ZC, Ren K, Liu X, Zhen LT, Guang HY. A high-density lipoprotein-mediated drug delivery system. Adv Drug Deliv Rev, 2016;106 (Pt A):132–47.
- Mooberry LK, Nair M, Paranjape S, McConathy WJ, Lacko AG. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier. J Drug Targeting, 2010;18(1):53–8.
- Rigotti A, Miettinen HE, Krieger M. The role of the high-density lipoprotein receptor SR-B1 in the lipid metabolism of endocrine and other tissues. Endocrine Rev, 2003;24(3):357–87.
- Sun WT, Huang GH, Ye JS, Zhang N. Determination of encapsulation efficiencies of liposomes and nanoliposomes by protamine aggregation method. China Pharm J, 2006;41(22):1716–20.
- Wang Y, Zhang QJ, Liu J, Liu Y, Han S, Zhang QS, Chen Y, Zhou YP. Synthesis and antitomor activities of garcinia glycosides. Chin J New Drugs, 2013;22(23):2739–44.
- Zhang W, Torabinejad M, Li Y. Evaluation of cytotoxicity of MTAD using the MTT-tetrazolium method. J Endodontics, 2003;29(10):654–7.
- Zhu QL, Zhou Y, Guan M, et al. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy. Biomaterials, 2014;35(22):5965–76.